Wider surgical margins may not mean better cancer control, finds large-scale treatment trial
Wider surgical margins may not mean better cancer control, finds large-scale treatment trial UC Davis Health
1636 материалов по теме, собраны автоматически из проверенных источников
Wider surgical margins may not mean better cancer control, finds large-scale treatment trial UC Davis Health
Wider surgical margins may not mean better cancer control, finds large-scale treatment trial UC Davis Health
Wider surgical margins may not mean better cancer control, finds large-scale treatment trial UC Davis Health
Erika Ruiz-Garcia Highlights GI Cancer Research in Front of 40,000 Attendees at ESMO 2026 Oncodaily
Rapidly dividing cancer cells can develop DNA mutations that produce abnormal proteins called antigens, which are unique to each patient's cancer. Scientists are now testing personalized cancer vaccines that target these neoantigens and prevent cancer from returning after treatment.
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators. The findings suggest new therapeutic strategies for a variety of cancer types.
Turning Cancer Research Into Action Through Storytelling and Strategic Communication - NCI Center for Global Health Oncodaily
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
Genmab Shares Hit Record as Cancer Trial Extends Drugmaker’s Run Bloomberg.com
Wei Zhang: Hanes and Willis Family Professorship Fuels Innovation in Cancer Research Oncodaily
Lilly reports nearly 80% of patients saw ovarian tumors shrink in clinical trial Indianapolis Business Journal
Artificial intelligence can be helpful in analyzing medical images and support radiotherapy planning workflows. However, huge amounts of sensitive patient data are needed to train robust AI models. Researchers at the Karlsruhe Institute of Technology (KIT) have investigated how hospitals can jointly develop AI models…
Endometrial Cancer Drug Reduced Death Risk by 32% in Phase 3 Trial Technology Networks
Vall d’Hebron recognised by the OECI as a Comprehensive Cancer Centre with Research Excellence VHIO